Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for…
Personalised Medicine: Economic Incentives for Evidence Generation
28 October 2013
Four types of economic incentives for drugs and diagnostics are essential to encouraging more rapid progress in personalised medicine. Adrian Towse, OHE’s Director, and Lou Garrison,…
Third Edition of OHE’s Guide to Health Economic Evaluation Released
12 September 2013
OHE today released the third edition of its popular primer, Health Economics: An Introduction to Economic Evaluation, authored by Gisela Kobelt, who has extensive hands-on experience…
ISPOR Task Force Report on Performance-Based Risk-Sharing Arrangements
28 August 2013
Best practices for performance-based risk-sharing arrangements in health care are described in detail in this new ISPOR report, developed by a task force co-chaired by Professor…
Special Issue of EJHE Examines Progress on Refinement of the EQ-5D
13 August 2013
Just released online [open access] is a special issue of the European Journal of Health Economics on the development of new research methods for the valuation…
OHE at iHEA: HTA in Emerging Markets, Personalised Medicine, EQ-5D mapping
6 August 2013
OHE was involved in several sessions at the 9th World Congress of the International Heath Economics Association (iHEA). Prof Adrian Towse, OHE’s Director, and Prof Lou…
What Is the Role of Cost-Effectiveness Evidence in US Health Care?
31 July 2013
At an OHE seminar last week, Dr James Chambers of Tufts Medical School examined the role cost-effectiveness evidence plays in health care resource allocation in the…
Measuring the Relationship Between Health and Subjective Well-being
24 July 2013
Significantly increases of wealth and health in the Western world over the past 50 years do not appear to have produced an equivalent increase in societal…
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
Professor Adrian Towse, OHE’s Director, joined Professor Sir John Bell and Professor Andrew Morris at the Science Media Centre last week to launch Realising the Potential…